SEROTONIN IS INVOLVED IN THE PATHOGENESIS OF HYPERTENSION DEVELOPING DURING ERYTHROPOIETIN TREATMENT IN UREMIC RATS

被引：17
作者：
AZZADIN, A
MYSLIWIEC, J
WOLLNY, T
MYSLIWIEC, M
BUCZKO, W
机构：
[1] MED ACAD BIALYSTOK,DEPT PHARMACODYNAM,BIALYSTOK,POLAND
[2] MED ACAD BIALYSTOK,DEPT NEPHROL,BIALYSTOK,POLAND
来源：
THROMBOSIS RESEARCH | 1995年 / 77卷 / 03期
关键词：
ERYTHROPOIETIN; UREMIA; SEROTONIN; HYPERTENSION;
D O I：
10.1016/0049-3848(95)91609-O
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The aim of this study was to investigate the mechanism of erythropoietin-induced hypertension in respect to its action on blood serotonergic system. The experiment was carried out on healthy rats and animals with experimental chronic renal failure. Erythropoietin (rHuEPO) injected into the healthy and uremic rats caused an increase in systolic blood pressure. This effect was completely abolished by ketanserin, an antagonist of 5-HT2 receptors. Concomitantly a rise in blood and platelet serotonin concentration was observed. It is concluded that serotonin may play a role in the development of hypertension caused by rHuEPO. Moreover, ketanserin may serve as a drug for pharmacological protection of rHuEPO-induced rise of blood pressure in uremia.
引用
收藏
页码：217 / 224
页数：8
相关论文
共 21 条
[1]   SEROTONIN IS INVOLVED IN SOME EFFECTS OF ERYTHROPOIETIN [J].
AZZADIN, A ;
BIALKOWSKA, A ;
PAWLAK, D ;
CHABIELSKA, E ;
MAZERSKA, M ;
MYSLIWIEC, M ;
BUCZKO, W .
THROMBOSIS RESEARCH, 1992, 65 (4-5) :657-661
[2]  
AZZADIN A, 1992, NEPHROL DIAL TRANSPL, V7, P882
[3]  
DRUMMOND AH, 1974, THROMB DIATH HAEMO, V31, P336
[4]   VASCULAR REACTIVITY IN CHRONIC GOLDBLATT 2 KIDNEY ONE CLIP HYPERTENSIVE RATS [J].
DUARTE, J ;
ANDRADE, J ;
VARGAS, F .
EXPERIENTIA, 1990, 46 (08) :868-869
[5]  
EGGENA P, 1991, AM J PHYSIOL, V254, pR1165
[6]  
FETKOVSKA N, 1990, CARDIOVASC DRUG THER, V1, P105
[7]  
FRITSCHKA E, 1990, BR J CLIN PHARM, V16, P345
[8]   ANEMIA OF RENAL-FAILURE - USE OF ERYTHROPOIETIN [J].
HUMPHRIES, JE .
MEDICAL CLINICS OF NORTH AMERICA, 1992, 76 (03) :711-725
[9]   IMPAIRED ERYTHROCYTE FLUIDITY DURING TREATMENT OF RENAL ANEMIA WITH ERYTHROPOIETIN [J].
LINDE, T ;
SANDHAGEN, B ;
DANIELSON, BG ;
WIKSTROM, B .
JOURNAL OF INTERNAL MEDICINE, 1992, 231 (06) :601-606
[10]   COAGULATION STUDIES AND FISTULA BLOOD-FLOW DURING ERYTHROPOIETIN THERAPY IN HEMODIALYSIS-PATIENTS [J].
MACDOUGALL, IC ;
DAVIES, ME ;
HALLETT, I ;
COCHLIN, DL ;
HUTTON, RD ;
COLES, GA ;
WILLIAMS, JD .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1991, 6 (11) :862-867
123